WELLS FARGO & COMPANY/MN - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 1 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2022$0–125
-61.9%
0.00%–
Q4 2021$0–3280.0%0.00%–
Q3 2021$0–3280.0%0.00%–
Q2 2021$0
-100.0%
3280.0%0.00%–
Q1 2021$1,000
-97.1%
328
-97.7%
0.00%–
Q4 2020$35,000–14,464–0.00%–
 Download
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS PLC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS PLC shareholders